Cyprus vs Latvia: Cause of death, by non-communicable diseases, ages 60+, female
Cyprus
84.5%
in 2021
Latvia
84.1%
in 2021
Cyprus rank
30th
Latvia rank
32nd
Cause of death, by non-communicable diseases, ages 60+, female over time
- Cyprus
- Latvia
How they compare
Cyprus currently reports 84.5% against 84.1% in Latvia, a difference of 0.4%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Latvia ahead.
Cyprus ranks 30th and Latvia ranks 32nd of 185 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cyprus | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.2% | 95.7% | 2.5% | Latvia |
| 2010s | 91.9% | 96.7% | 4.7% | Latvia |
| 2020s | 87.2% | 89.2% | 2.0% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Cyprus or Latvia?
- Cyprus, at 84.5% against 84.1% in Latvia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Cyprus and Latvia?
- 0.4%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Latvia?
- 6 years are reported by both, from 2000 to 2021.
- How do Cyprus and Latvia rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Cyprus ranks 30th and Latvia ranks 32nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.